Clinical significance of post-prophylaxis cytomegalovirus infection in lung transplant recipients.
Jaamei, Nikta; Koutsokera, Angela; Pasquier, Jérôme; Mombelli, Matteo; Meylan, Pascal; Pascual, Manuel; Aubert, John-David; Manuel, Oriol.
Transpl Infect Dis
; 20(4): e12893, 2018 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-29603543
Role of Immunogenetics in the Outcome of HCMV Infection: Implications for Ageing.
CMV in critically ill patients: pathogen or bystander?
Controversies in the natural history of congenital human cytomegalovirus infection: the paradox of infection and disease in offspring of women with immunity prior to pregnancy.
Cytomegalovirus infections in lung and hematopoietic cell transplant recipients in the Organ Transplant Infection Prevention and Detection Study: A multi-year, multicenter prospective cohort study.
Quantitative temporal viromics: an approach to investigate host-pathogen interaction.
The pathogenesis of human cytomegalovirus.
Congenital cytomegalovirus infection in Central Germany: an underestimated risk.
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation.
Prevalence and clinical aspects of CMV congenital Infection in a low-income population.
Evolution of human cytomegalovirus-seronegative donor/-seropositive recipient high-risk combination frequency in allogeneic hematopoietic stem cell transplantations at Institute of Hematology and Blood Transfusion during 1995-2014.